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A B S T R A C T
The selective modulation of immunity is an emerging concept driven by the vast advances in our understanding
of this crucial host defense system. Invertebrates have raised researchers’ interest as potential sources of new
bioactive molecules owing to their antibacterial, anticancer and immunomodulatory activities. A
LipoPolySaccharide (LPS) challenge in the ascidian Ciona intestinalis generates the transcript, Ci8 short, with cis-
regulatory elements in the 3′ UTR region that are essential for shaping innate immune responses. The derived
amino acidic sequence in silico analysis showed speciﬁc binding to human Major Histocompatibility Complex
(MHC) Class I and Class II alleles. The role of Ci8 short peptide was investigated in a more evolved immune
system using human Peripheral Blood Mononuclear Cells (PBMCs) as in vitro model. The biological activities of
this molecule include the activation of 70 kDa TCR ζ chain Associated Protein kinase (ZAP-70) and T Cell
Receptor (TCR) Vβ oligo clonal selection on CD4+ T lymphocytes as well as increased proliferation and IFN-γ
secretion. Furthermore Ci8 short aﬀects CD4+/CD25high induced regulatory T cells (iTreg) subset selection which
co-expressed the functional markers TGF-β1/Latency Associated Protein (LAP) and CD39/CD73. This paper
describes a new molecule that modulates important responses of the human adaptive immune system.
1. Introduction
The immune system is composedof a very complex and dynamic
network of cell subsets and mediators that promote host defense from
infectious agents or tumor cells and maintain immunological tolerance in
the organisms (Brodin and Davis, 2017; Parkin and Cohen, 2001). The
vertebrate immunity is classically divided into innate and adaptive im-
mune systems that act in interdependent ways based on bidirectional
cross-talk (Chaplin, 2010; Paul, 2011; Lanier and Sun, 2009). Innate
immunity represents a conserved, complex and multi-pronged response to
overcoming infection that is present in all complex host species. It is well
known that the innate immune system not only provides the ﬁrst line of
defense in the immune response but can also induce and regulate many
diﬀerent adaptive immunity functions (Lanier and Sun, 2009; Iwasaki and
Medzhitov, 2015). Many discoveries have been made in the ﬁeld, but the
mechanisms by which the innate immune system can control adaptive
immunity remain to be fully clariﬁed. Invertebrates produce a large
number of bioactive molecules which have been proven to fulﬁll im-
portant immunological roles such as antibacterial or anticancer activities
(Otero-González et al., 2010; Cheung et al., 2015; Suarez-Jimenez et al.,
2012). A recent idea is to use invertebrates as a source of molecules with
potential immunoregulatory activities to improve strategies for studying
human immune system responses (Davis, 2008; Germain and
Schwartzberg, 2011). The ascidian Ciona intestinalis, which is a descen-
dant of the last common ancestor of all vertebrates, is a powerful model
for studying innate immunity. However Ascidians occupy a key
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phylogenetic position in chordate evolution and are considered the sister
group of vertebrates (Zeng and Swalla, 2005; Delsuc et al., 2006). They
are proto-chordates that possess an innate immune system, including
inﬂammatory humoral and cellular responses (Shida et al., 2003). Chal-
lenge with Microbe-Associated Molecular Patterns (MAMPs), such as the
Gram-negative LPS, induces inﬂammatory-like reactions in the pharynx
(immunocompetent organ). These responses can induce several im-
munological phenomena, including the expression of characteristic innate
immune genes and a repertoire of innate eﬀectors (e.g., TLRs, TNF, IL-
17s, TGF beta, complement components, and galectin-like) (Parrinello
et al., 2008; Vizzini et al., 2016). Although a variety of diﬀerent MAMPs
induce Ciona TLRs, LPS does not activate TLR expression directly, as with
TLR4 in vertebrates, suggesting the presence of alternative LPS sensors
(Vizzini et al., 2015). In vertebrates, the development of the adaptive
immune system is linked to the acquisition of the enzyme machinery
encoded by Recombination Activating Genes (RAG) that provide the re-
arrangement of immunoglobulin (Ig) and TCR genes. Analysis of Ciona
intestinalis genome sequences did not reveal the pivotal genes and mole-
cules for adaptive immunity, such as MHC genes, TCRs, or dimeric Igs
(Dehal et al., 2002; Azumi et al., 2003). Nevertheless, sequence analyses
have allowed the recognition of two Ig domain-containing regions, key V
regions, the essential feature of an Ig superfamily VC1-like core trait,
presumptive proto-MHC regions scattered throughout the genome, and
three types of genes with receptor-like V-C architecture (Du Pasquier,
2004; Du Pasquier et al., 2004). In a previous paper (Vizzini et al., 2013),
we demonstrate that an LPS challenge induces the activation of Coding
Region Alternative PolyAdenylation (CR-APA) mechanisms (Carpenter
et al., 2014) responsible for the generation of a mRNA named Ci8 short,
which is signiﬁcantly enhanced in the inﬂammation process and strongly
activated in immune cells. In the present study we determine the con-
tribution of these innate immune-related molecule to act on speciﬁc as-
pects of human adaptive immune system functions by using PBMCs as an
experimental model. We performed a detailed study by in silico analysis of
cis-regulatory elements in the 3′ UTR mRNA region and deduced amino
acid sequence. A Ci8 short synthetic peptide was used to set up an an-
tigen-speciﬁc experimental system to analyze the eﬀect on TCR activation
mediated by the ZAP-70 checkpoint and explore the Vβ repertoire of
CD4+ and CD8+ lymphocytes. Moreover, we evaluated diﬀerent para-
meters of activation of immune cells including the proliferation rate of
CD16+/CD56+ NK cells, CD4+ and CD8+ lymphocytes and secretion of
diﬀerent cytokines such as IFN-γ and IL-10. Finally, the Ci8 short peptide
was used to study the phenotype and expression of functional markers of
induced regulatory T cells (iTreg) such as CD25, TGF-β1 Latency-Asso-
ciated Peptide (LAP), CD39 and CD73.
2. Materials and methods
2.1. Bioinformatic analysis
The Exon-Intron Graphic Maker (http://wormweb.org/exonintron)
was used to create an image of the genomic organization of the Ci8
gene. To characterize the 3′UTR region, a computational analysis was
performed using the Regulatory RNA Motifs and Elements Finder tool
(http://regrna.mbc.nctu.edu.tw/html/prediction.html). Physical and
chemical parameters, such as molecular mass and theoretical isoelectric
point, were computed using the Prot-Param tool on ExPASy (http://
www.expasy.org/tool/protparam/). The prediction of Major
Histocompatibility Complex (MHC) binding aﬃnity sites were studied
using the immunological tool including the Immune Epitope Database
and Analysis Resource (IEDB) (www.iedb.org). MHC Class I binding
peptides prediction was performed using a Consensus method based on
top two predictive methods, an Artiﬁcial Neural Network (ANN) and
Stabilized Matrix Method (SMM). The output of prediction is: percentile
rank (cut oﬀ 0.5) and ANN and SMM IC50 value, (peptides with IC50
values< 50 nM are considered high aﬃnity, weakly binding peptides
had IC50 value below 500 nM). MHC Class-II binding peptides
prediction was performed using a consensus methods based on an ap-
proach which calculates the median rank of the top three predictive
methods for each MHC class II molecules: Combinatorial library
(Comb.lib), SMM-align (netMHCII-1.1) and NN-align (netMHCII-2.2).
2.2. Reagent




was synthesized by Selleck Chemicals. Ci8 short peptide was re-
suspended at 10 μg/μl concentration in LAL Reagent Water (Lonza,
BioWhittaker, USA), aliquoted and stored at −80 until use.
2.3. Human leukocyte specimens and cell lines
Freshly isolated Peripheral Blood Mononuclear Cells (PBMCs) were
prepared by standard Ficoll (GE Healthcare Life Sciences) density gra-
dient separation from blood of four healthy volunteer donors after
obtaining written informed consent. The Prostatic Adenocarcinoma cell
line PC-3 (NCI-PBCF-CRL1435 Prostate Adenocarcinoma) was pur-
chased from American Type Culture Collection (ATCC). PBMCs and PC-
3, except where otherwise indicated, were maintained in RPMI 1640
(Gibco™, Thermo Fisher Scientiﬁc) containing 10% FCS serum (Gibco™,
Thermo Fisher Scientiﬁc), 100 U ml−1 penicillin/100 mg ml−1 strep-
tomycin (Gibco™, Thermo Fisher Scientiﬁc), 1% Non-Essential Amino
Acids (Gibco™, Thermo Fisher Scientiﬁc), and 1% sodium pyruvate
(Gibco™, Thermo Fisher Scientiﬁc), at 37 °C in a humidiﬁed incubator
with 5% CO2.
2.4. Cell viability assay
The eﬀect of the Ci8 short peptide on PC-3 and PBMCs cell growth
was determined using the CellTiter 96® Aqueous One Solution Cell
Proliferation Assay kit (Promega, Madison, Wisconsin, USA) according
to the manufacturer’s protocol. In brief, PC-3 cells were seeded at a
concentration of 5 × 103 cells/well, while PBMCs was seeded at a
concentration of 15 × 104 cells/well on 96-wells microtiter plates
(Nunc, Roskilde, Denmark). PBMCs and PC-3 were treated with dif-
ferent concentrations of Ci8 short peptide (0,1 μl/ml, 1 μl/ml, 10 μl/ml
and 100 μl/ml) and incubated at 37 °C in a humidiﬁed incubator with
5% CO2 for 24 h and 48 h. Assays were performed in triplicates. The
absorbance of the dissolved formazan was measured in an iMark™
Microplate Absorbance Reader (BioRad, Hercules, CA, USA) at 490 nm.
Cell viability percentage was determined as the ratio between the ab-
sorbance of treated and control cells x 100.
2.5. Hemolysis assay
Heparinized blood samples were obtained from two healthy human
subjects. Ci8 short peptide at concentrations of 1 μl/ml, 10 μl/ml and
100 μl/ml was added to an 8% human erythrocytes solution and in-
cubated at 37 °C for 30 min. The samples were centrifuged at 2000 x g
for 5 min and the supernatant absorbance was measured at 415 nm
through the iMark™ Microplate Absorbance Reader (BioRad, Hercules,
CA, USA) to determine the percentage of hemolysis. Hemolysis was
induced with 1X PBS, and Triton X-100 1% solution was taken at 0%
and 100%. Hemolysis percentage was determined as the ratio between
the OD of treated cells and positive control cells x 100.
2.6. Flow cytometry
All staining were performed by adding the appropriate amount of
the ﬂuorochrome-conjugated antibody (according to antibody data
sheet), and stained at 4 °C for 30–45 min in 100 μl of FACS buﬀer
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(Phosphate Buﬀered Saline-PBS (Gibco™, Thermo Fisher Scientiﬁc)
with 1% FCS serum (Gibco™, Thermo Fisher Scientiﬁc) and 0.1% so-
dium azide). Excess of antibodies were removed by two consecutive
washings. Anti-human antibodies were used, purchased from BD
Bioscience Heidelberg, Germany (BD), Beckman Coulter, Brea, CA, USA
(BC) and Miltenyi Biotech, Bergisch Gladbach, Germany (MB): anti-
CD3-FITC (clone UCHT1, BC), CD4 FITC (clone VIT4, MB), anti-CD4
PC5 (clone 13B8.2, BC), anti-CD4 APC (clone 13B8.2, BC), anti-CD8
Paciﬁc Blue (clone B9.11, BC), anti-CD16 PC7 (clone 3G8, BC), anti-
CD14 PerCp (Clone TÜK4, MB), anti-CD25 PC7 (clone B1.49.9, BC),
anti-CD39 FITC (clone MZ18-23C8, MB), CD56 PC7 (BC), anti-CD73 PE
(clone AD2, MB), 7AAD (BD), anti-LAP APC (clone CH6-17E5.1, MB),
anti-ZAP70-PE (clone SBZAP, BC). Flow cytometry analysis were per-
formed using BD FACSCalibur (BD Bioscience, Heidelberg, Germany),
CyAn™ADP Analyzer (Beckman Coulter, Brea, CA, USA) and data were
analyzed with FlowJo software (Tree star Inc., Ashland, OR, USA).
2.7. CFSE proliferation assay
Determination of PBMC proliferation, from four healthy donors, was
conducted by use of 5 μM 5(6)-Carboxy-Fluorescein Diacetate
Succinimidyl Ester solution (CFSE) (Molecular Probe, Eugene, OR, USA)
as previously described (Bonura et al., 2007). CFSE labelled PBMCs
were seeded at a concentration of 1 × 106 cells/ml, and incubated with
Ci8 short peptide at the concentrations of 1 μg/ml and 10 μg/ml.
Background proliferation was measured in the unstimulated sample. A
minimum of 200,000 events were collected and acquired on a CyAn™
ADP Analyzer (Beckman Coulter, Brea, CA, USA). Analysis gates were
set on proliferating lymphocytes by forward and side scatter proﬁle and
by the exclusion of 7AAD+ cells. The percentages of CD4+, CD8+ and
CD16+/CD56+ proliferating cells were selected on a CD4 vs CFSE, CD8
vs CFSE and CD16/CD56 vs CFSE dot plots.
2.8. ZAP-70 intracellular staining
PBMC from four healthy donors were seeded at a concentration of
1 × 106 cells/ml, incubated with Ci8 short peptide at a concentration
of 10 μg/ml and harvested at 24 h for intracellular determination of
ZAP-70 expression. Cells were treated with PerFix-nc-kit (Beckman
Coulter, Brea, CA, USA), according to the manufacturer’s protocol op-
timized for PBMCs. A minimum of 50,000 events were acquired. A
lymphocyte gate based on forward and side scatter properties was set:
CD3+ lymphocytes were selected on SSC vs CD3 dot plot, CD3+CD4+
and CD3+CD8+ lymphocytes were selected on a CD4 vs CD8 dot plot.
The percentage value of CD3+CD4+ ZAP-70+ cells and of CD3+CD8+
ZAP-70+ was deﬁned with a count vs ZAP-70 histogram.
2.9. Quantitative analysis of the TCR Vβ repertoire
The study the TCR repertoire ﬂow cytometry analysis was per-
formed using the IOTest® Beta Mark multianalysis tool (Beckman
Coulter, Brea, CA, USA), which consists of ﬂuorochrome conjugated
monoclonal antibodies that identify 24 TCR Vβ subfamilies, covering
about the 75% of the normal human T cells. Peripheral blood samples
from four healthy donors were collected in tubes containing antic-
oagulant heparin and were stained within 2 h and used as a control.
Subsequently, isolated PBMCs were seeded at a concentration of
1 × 106 cells/ml and treated with Ci8 short peptide at a concentration
of 10 μl/ml and harvested at day 7. For each sample, 20 μl of a mixture
of three distinct anti-Vβ monoclonal antibodies were added according
to the manufacturer’s protocol. A minimum of 50,000 lymphocyte
events were acquired. A lymphocyte gate based on forward and side
scatter properties was set. CD4+ and CD8+ lymphocytes were selected
on a SSC vs CD4 or SSC vs CD8 dot plot. CD4+ and CD8+ lymphocytes
TCR Vβ repertoire analysis was set on a FITC vs PE dot plot, which
identiﬁed subpopulation clonality of diﬀerent T cells.
2.10. Cytokines secretion assay
PBMCs from four healthy blood donors were seeded at a con-
centration of 10 × 106 cells/ml in RPMI 1640 (Gibco™, Thermo Fisher
Scientiﬁc) containing 10% AB serum (Euroclone, Milan, Italy),
100 U ml−1 penicillin (Gibco™, Thermo Fisher Scientiﬁc), 100 mg ml−1
streptomycin (Gibco™, Thermo Fisher Scientiﬁc), 1% Non-Essential
Amino Acids (Gibco™, Thermo Fisher Scientiﬁc), and 1% sodium pyr-
uvate (Gibco™, Thermo Fisher Scientiﬁc), at 37 °C in a humidiﬁed in-
cubator with 5% CO2. Cells were incubated with Ci8 short peptide at
concentrations of 20 μg/ml for 16 h. The speciﬁc selection of IFN-γ and
IL-10 producing cells was performed by using the IFN-γ Secretion Assay
Cell Enrichment and Detection Kit (PE) (Miltenyi Biotech, Bergisch
Gladbach Germany) and the IL-10 Secretion Assay Cell Enrichment and
Detection Kit (PE) (Miltenyi Biotech, Bergisch Gladbach, Germany)
according to the manufacturer’s instructions. IFN-γ and IL-10 positive
cell fractions were magnetically sorted and stained with the appropriate
set of antibodies. Immediately before ﬂow cytometry acquisition,
Propidium Iodide (PI) (0.5 mg/ml, Sigma-Aldrich, St. Louis, MO, USA)
was added to each sample in order to distinguish live and dead cells. A
minimum of 100,000 events was collected. A lymphocyte gate based on
forward and side scatter properties was set. Dead cells and monocytes
were excluded on a PI vs CD14 dot plot. The cytokine+/CD4+ cells
were selected on a cytokine vs CD4 dot plot. For each sample we
evaluated Coeﬃcient of Variation (CV) as a statistical parameter.
2.11. Studying T regulatory cells subpopulation
PBMCs from four healthy donors were seeded at a concentration of
1 × 106cells/ml, treated with Ci8 short peptide at a concentration of
10 μl/ml, and harvested at days 6, 7 and 8. A minimum of 100,000
events was collected. Analysis gates were set on lymphocytes using
forward and side scatter proﬁles. The gate to deﬁne the CD4+CD25high
population was set according to the level of expression of CD25 on
CD4neg T cells (Baecher-Allan et al., 2001). The percentage value of
CD4+CD25highCD39+CD73+ was deﬁned on a CD39 vs CD73 dot plot;
the relative CD39 MFI and CD73 MFI variations were evaluated. The
percentage value of CD4+CD25highLAP+ cells was selected on a count
vs LAP histogram and the relative LAP MFI variation was evaluated.
The percentage value of CD4+CD25highCD39+CD73+ LAP+ cells was
deﬁned with a count vs LAP histogram and the LAP MFI variation was
evaluated.
2.12. Statistical analysis
The statistical signiﬁcance of the diﬀerences between data sets was
assessed by a two-tailed unpaired Student’s t-test, unless stated other-
wise. The results are expressed as the mean values ± SD. Diﬀerences
with a P value<0.05 are marked with asterisks. ns, not signiﬁcant;
*P < 0.05; **P < 0.01; ***P < 0.001.
3. Results
3.1. LPS challenge in the ascidian Ciona intestinalis induces a CR-APA
mechanism that generates the transcript Ci8 short with GAIT and ARE cis-
regulatory elements in the 3′ UTR region.
In a previous paper, we reported that LPS challenge in Ciona in-
testinalis induces a CR-APA event in the annotated Ci8 gene (Vizzini
et al., 2013). This gene contains ﬁve exons and four introns (Fig. 1A)
encoding for the following two alternative transcripts: Ci8 long and a
short variant named Ci8 short derived by an intronic polyadenylation
signal within the ﬁrst intron (Fig. 1B). To study the structural elements
of 3′ UTR involved in posttranscriptional regulation, we performed an
in silico analysis using the REGRNA 2.0 database (Chang et al., 2013). In
the 3′UTR of Ci8 short, we identiﬁed diﬀerent cis-regulatory elements
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essential for shaping innate immune responses. In particular, we de-
tected an AU Rich Element (TTATATTTATTTG) (ARE) (Fig. 1C) and an
Interferon-γ-Activated Inhibitor of Translation element (TAAATGTTG-
TTTGTGTTAAAGCATTTA) (GAIT). ARE elements are major regulators
of the mRNA stability of early and transient transcripts that are induced
in LPS-stimulated immune responses. In addition to ARE, GAIT ele-
ments have an important role in gene-speciﬁc translational control in
innate immunity. These elements result in the absence of the Ci8 long 3′
UTR region, where Musashi Binding Elements (MBEs) (Fig. 1C) are
instead identiﬁed as being involved in mRNA translational control
during cell cycle progression. However Ci8 short transcript is sig-
niﬁcantly enhanced during the inﬂammatory process in the early hours
(1–12) of the LPS challenge compared to Ci8 long transcript (Vizzini
et al., 2013) and for all of these results we must assume a possible role
of Ci8 short in controlling both the magnitude and duration of the in-
ﬂammatory response in Ciona intestinalis.
3.2. In silico analysis of Ci8 short physical-chemical and immunological
properties
An in silico analysis of Ci8 short deduced amino acidic sequence was
performed using the Expasy ProtParam server (Gasteiger et al., 2005) to
deduce physical-chemical properties and the Immune Epitope Database
and Analysis Resource (IEDB) (Peters et al., 2005; Vita et al., 2015) to
predict the possible MHC Class I and Class II binding aﬃnity sites. Ci8
short mRNA codiﬁes for a peptide of 73 AA with a predicted molecular
size of 7.3 kDa, a pI of 4.00 and a total number of negatively charged
residues (Asp + Glu = 1). Within the 73 AA deduced sequence, a se-
quence from 55 to 63 AA was identiﬁed with good binding prediction
(Percentile rank 0.1) for MHC Class I Alleles as HLA-A*02:06 and from
42 to 50 AA for HLA-A*01:01 (Percentile rank 03), (Table 1 supple-
mentary). The MHC Class II binding peptide prediction describes the
following two diﬀerent putative binding sequences: a peptide sequence
between AA 49–67 (Percentile rank 1.45/2.03) that can bind to the
HLA-DRB4*01:01 Allele and a sequence at position AA 4–22 that can
recognize HLA-DRB1*13:02 (Percentile rank 3.41/3.85) (Table 2 sup-
plementary). These data highlight that there are speciﬁc amino acid
short peptides that can bind to diﬀerent human HLA class I and HLA
class II alleles.
3.3. Ci8 short peptide induces the expression of ZAP-70 on human T
lymphocytes
The T cell epitope prediction shows putative Ci8 short binding with
MHC class I and II for diﬀerent peptide sequences and alleles. To study
Ci8synthetic peptide immunological characteristics, we selected human
PBMCs as an in vitro system. First, we demonstrate that the peptide did
not show cytotoxic activity in PBMCs and Prostate Adenocarcinoma
(PC-3) cells after 24 and 48 h stimulation. The peptide demonstrated
the same lack of cytotoxic activity at a higher concentration and did not
induce hemolytic activity on Red Blood Cells (RBCs) (supplementary
Fig. 1 for details). To investigate possible eﬀects of the peptide on the
human immune system, we analyzed ZAP-70 expression, a key sig-
naling component of antigen recognition mediated by TCR. Flow cy-
tometric analysis was performed on CD3+CD4+ and CD3+CD8+T
lymphocytes to evaluate the percentage of ZAP-70+ cells and ZAP-70
Mean Fluorescence Intensity (MFI) values. The cells were incubated
with Ci8 short peptide for 24 h and unstimulated samples were used as
a negative control. Fig. 2A and B shows the histograms representative of
one experiment where the ZAP-70 MFI variation is evident for
CD3+CD4+ and CD3+CD8+ T lymphocytes, respectively. Fig. 2C
summarizes ZAP-70 MFI values for all donors and shows a trend for
increased ZAP-70 in CD3+CD4+ and CD3+CD8+ cells in the presence
of Ci8 short peptide in comparison to the negative control. Further-
more, the peptide induces a statistically signiﬁcant increase only for
CD3+CD4+ZAP70+ cells (P-value = 0.048) (Fig. 2D). Together these
results demonstrate that Ci8 peptide increases the expression of ZAP-70
tyrosine kinase particularly on CD4+ T lymphocytes.
3.4. Ci8 short modulates speciﬁc TCR Vβ in CD4+ T lymphocytes
T-cell mediated immune responses are characterized by activation
and subsequent clonal expansion of antigen-speciﬁc cells. T lymphocyte
repertoire variations can be evaluated by ﬂow cytometric quantiﬁcation
of TCR Vβ family subgroups after antigen stimulation. Therefore, we
used a panel of 24 monoclonal antibodies that stains approximately
75% of the entire T repertoire to study the selective responses of each
Vβ subgroups which were evaluated in all donors on CD4+ and CD8+
cells in control samples without stimulation and in cultures in presence
of Ci8 short peptide for seven days. Figs. 2 and 3 supplementary data
show the gating strategy for 24 TCR Vβ clone analysis in a re-
presentative experiment on CD4+ and CD8+ lymphocytes. Fig. 3A and
B shows the clonograms that summarize the patterns of Vβ family ex-
pression. Selective expansion of CD4+ and CD8+ of speciﬁc Vβ sub-
groups was considered signiﬁcant when the% of Vβ in the stimulated
cultures was elevated at statistically signiﬁcant levels compared to the
control group. All of the means and P-value data are reported in Sup-
plementary Table 3 for CD4+ and CD8+ T subsets. Signiﬁcant results
were obtained for Vβ20 (P-values = 0.005), Vβ2 (P-values = 0.003)
and Vβ21.3 (P-values = 0.002) families. In addition, we also observed
Fig. 1. LPS challenge in the ascidian Ciona intestinalis induces a Coding Region Alternative PolyAdenylation (CR-APA) event in the annotated Ci8 gene. An intronic polyadenylation signal
within the ﬁrst intron leading to the transcription of a variant named Ci8 short. A. Intron-exon organization of the Ci8 gene (ENSCING00000009651): the thin lines represent the four
introns and the open boxes indicate the ﬁve exons. Exon 1 (Ex1) is shown as a red open box. Exons from 2 to 5 are shown as blue opened boxes. B. LPS challenge leading to the
transcription of a shorter mRNA, Ci8 short, including the ﬁrst exon 1 (red open box) C. Ci8 short and Ci8 long transcripts show diﬀerent 3′ UTR cis-regulatory element organization. Ci8
short present a GAIT element (Interferon-γ-Activated Inhibitor of Translation, light blue open box) and ARE element (AU Rich Elements, orange open box). Ci8 long 3′ UTR containing
MBE (Musashi Binding Element, green open boxes). CDS (Coding DNA Sequence). (For the interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article).
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an increase for TCR Vβ16 (P-values = 0.031), Vβ13.1 (P-va-
lues = 0.026), Vβ8 (P-values = 0.020), Vβ14 (P-values = 0.028) and
Vβ7.2 (P-values = 0.033). For the CD8+ subset we could detect a P-
value = 0.007 for the Vβ14 clone (Fig. 3B) and P-values = 0.031 for
Vβ16. Taken together, these data suggest that Ci8 short peptide induces
an oligoclonal response in TCR Vβ20, Vβ2 and Vβ21.3 families pri-
marily in peripheral CD3+CD4+T lymphocytes. In CD3+CD8+ lym-
phocytes, Ci8 short peptide induces a response only for TCR Vβ14.
3.5. Human CD4+ T lymphocytes proliferate in response to Ci8 short
peptide
In our system, we demonstrated the engagement of TCR and ZAP-70
tyrosine kinase activation; we next asked whether the peptide does
increase the proliferation rate of innate and adaptive human immune
cells involving CD4+, CD8+ and CD16+/56+ lymphocytes. For eight
days human PBMCs from four healthy donors were incubated in pre-
sence of two diﬀerent concentrations of Ci8 short (1 and 10 μg/ml) or
without Ci8 short as a negative control (Bonura et al., 2007); the pro-
liferation rate was studied using CFDA-SE staining at 6, 7 and 8 days
(Supplementary Fig. 4 for gating strategy). Fig. 4A shows the dot plots
of a representative experiment where CFSE+/CD4+ cells increase at
days 6 and 7 after antigen stimulation and with higher values at 10 μg/
ml. The same experiments were performed to study the proliferative
response of CD8+ lymphocytes and the CD16+/CD56+ NK cell com-
partment. For CD8+ lymphocytes we could no detect any diﬀerence in
the proliferation rate in three out of four subjects (Fig. 4A the dot plots
of a representative experiment at day 6) in comparison to the control
group. The analysis performed on CFSE+/CD16+/CD56+ cells de-
monstrated that there are no signiﬁcant changes in the percentage of
proliferating cells in response to the Ci8 short (Fig. 4A the dot plots of a
representative experiment at day 6). Fig. 4B summarizes the CD4+
proliferation response for all donors and describes a statistically sig-
niﬁcant increase in CFSE+/CD4+ T cells compared to the unstimulated
sample at day 6 (P-value = 0.04) and day 7 (P-value = 0.04) when
cells were stimulated with 10 μg/ml of peptide. In summary, our results
suggest that the TCR activation drives CD4+ T lymphocytes mainly to a
proliferative response, but no signiﬁcant data were obtained for CD8+
cells and NK cells.
3.6. Ci8 short induces IFN-γ secretion by CD4+ T lymphocytes
Next, we analyzed whether the treatment with Ci8 short changes the
cytokine proﬁle in our experimental system. In particular, we have
focused on the eﬀect of antigen on IFN-γ and IL-10 investigating human
T cells by using an aﬃnity matrix technology, which allows the en-
richment of viable cytokine+ cells and analyses cells down to fre-
quencies of 0.01–0.1% (rare population) both as a% of positive cyto-
kine-secreting cells and as MFI. For each sample, we evaluated the
Coeﬃcient of Variation (CV) as a parameter; in all experiments, CVs
are< 5. Flow cytometric analysis performed on live PBMCs show an
interesting increase in the IFN-γ+ MFI value in three out of four sub-
jects 16 h post-stimulation compared to the negative control (Fig. 5A).
To understand which subsets of PBMCs can produce IFN-γ, positive
fractions were stained with anti-CD4 antibody after the enrichment
procedure (supplementary Fig. 5 for gating strategy). All donors
Fig. 2. Ci8 short peptide induces the activation of ZAP-70 tyrosine kinase on T lymphocytes.
A and B. Representative histograms of ZAP-70 in CD3+CD4+ and CD3+CD8+ cells after a 24 h stimulation with Ci8 short peptide at 10 μg/ml (blue histograms) and an unstimulated
sample (red histograms). C. Histograms show MFI values of ZAP-70 expression described as the mean values ± SD of four independent experiments for cultures without stimuli (white
boxes) and cultures treated with Ci8 short (black boxes) for CD3+CD8+ and CD3+CD4+T Lymphocytes. D. Histograms of% ZAP-70+ cells of CD3+-CD4+-ZAP-70+ and CD3+-CD8+-
ZAP-70+ cell for unstimulated samples (white boxes) and Ci8 short samples (black boxes). Data are shown as the mean value ± SD and are representative of four independent
experiments. Statistical signiﬁcance was determined using Student’s t-tests (two-tailed): ns, not signiﬁcant; *P < 0.05. (For the interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article).
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demonstrated an increase in IFNγ+ CD4+ cells compared to the un-
stimulated sample; Fig. 5B summarizes CD4+ IFNγ+ cell percentage
values for all donors and indicates a positive, but not statistically sig-
niﬁcant, trend. With the same experimental set-up, we examined
whether Ci8 short peptide can induce IL-10 secretion, but we could not
observe any signiﬁcant change in IL-10 MFI values between the non-
stimulated and stimulated sample in all subjects. Furthermore, Ci8
peptide induces IL-10 secretion by both CD4− and CD4+ T lymphocytes
(data not shown).
3.7. Ci8 short peptide induced the expression of LAP+, CD39+/CD73+ on
CD4+CD25high lymphocytes
Next we investigated if stimulation of PBMCs (n = 4 donors) in-
creased the CD4+CD25high subsets. Fig. 6A shows the gating strategy
used for identifying these cells in agreement with Bacher-Allan et al.
(Baecher-Allan et al., 2001). CD4+CD25high positive cell percentage
increased signiﬁcantly at day 8 (P-value = 0.015), compared to Ci8
short peptide stimulated samples and the negative control (Fig. 6B).
The expression of high levels of CD25 is a useful and necessary
marker but is not suﬃcient for identifying complex and hetero-
geneous cell populations, such as human in vitro induced T reg.
Hence, this study focused on two diﬀerent inhibitory pathways for
iTreg mediated mechanisms, such as LAP and CD39/CD73. Thus, we
exploit a hierarchical gating strategy based on the selection of
CD4+CD25high T cells and then CD39/CD73 co-expression to evaluate
the percentage of double positive cells. Fig. 6C shows the dot plots of
a representative experiment indicating an increase in the number of
CD39+CD73+ in PBMCs challenged with antigen. This is true from
day 6–8, but with a clear peak of response at day 7. In this subject, the
% CD39+CD73+ increased to 22.5% in the Ci8 short sample com-
pared to the unstimulated cells. The expression of CD39 and CD73
markers was performed and the complete data analysis for all donors
is reported in supplementary Fig. 6 (A% CD4+CD25highCD39+CD73+
cells; B and C for CD39 MFI and CD73 MFI, respectively). Flow cy-
tometric analysis showed that the peptide induces a signiﬁcant in-
crease in the number of CD4+CD25high cells expressing the two
functional markers at day 6 (P-value = 0.014) and day 7 (P-
value = 0.034). Furthermore, MFI value trends for CD39 (Supple-
mentary Fig. 6 B) and CD73 (Fig. 6C) were analyzed, but a statisti-
cally signiﬁcant increase was only found for CD73 MFI at day 6 (P-
value = 0.0037) and day 7 (P-value = 0.037). Therefore, we next
examined whether CD4+CD25highCD39+CD73+ cells that increased
after the antigen challenge, also co-express LAP. In Fig. 6D, the
histograms of one representative experiment show the number of
positive cells that co-express the three functional markers studied
here, i.e., the value of LAP MFI in CD4+CD25highCD39+CD73+LAP+
cells. The diﬀerence between the unstimulated sample (below) and
the sample stimulated with Ci8 short (above) are described for every
day. For this subject, we detected a notable increase in
CD4+CD25highCD39+CD73+LAP+ cells at all time points but with
particularly signiﬁcant data at day 6 and 8. As conducted for the
CD39 and CD73 functional Treg analysis, we examined the expression
of the LAP marker on CD4+CD25high cells to understand if the TGF-β1
immunosuppressive pathway had a role in Ci8-mediated mechanisms
per se. The data are reported in supplementary Fig. 6D and E.
Fig. 3. T Cell Receptors Vβ repertoire on CD4+ and CD8+ lymphocytes stimulated with Ci8 short peptide. A. Clonogram of TCR Vβ repertoire on CD4+ lymphocytes. The% of cells
positive for speciﬁc Vβ clones detected for diﬀerent times after Ci8 short peptide stimulation at 7 days (black boxes) and in cultures without stimuli (control, white boxes) are described as
the mean values ± SD of four independent experiments. Statistical signiﬁcance was determined using Student’s t-tests (two-tailed): *P < 0.05, **P < 0.01. B. Clonogram of TCR Vβ
repertoire on CD8+ lymphocytes. The% of cells positive for speciﬁc Vβ clones detected at 7 days after Ci8 short peptide stimulation at 7 days (black boxes) and in cultures without stimuli
(control, white boxes) are described as the mean value ± SD of four independent experiments. Statistical signiﬁcance was determined using Student’s t-tests (two-tailed): *P < 0.05.
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CD4+CD25high LAP+ cells showed a signiﬁcant increase at day 6 (P-
value = 0.038) and day 8 (P-value = 0.023) and LAP MFI at day 6 (P-
value = 0.012) and day 8 (P-value = 0.021) (Supplementary Fig. 6D
and F). The ﬂow cytometric analysis indicates an increase in
CD4+CD25highCD39+CD73+LAP+ cell percentage at day 6 (P-
value = 0.014), 7 and day 8 (Fig. 6E). There is no statistically sig-
niﬁcant increase in CD39 MFI and CD73 MFI values in the stimulated
samples compared to the unstimulated ones (data not shown). LAP
Fig. 4. Ci8 short induces CD4+ T cell proliferation. Proliferation assay of 5(6)-Carboxy-Fluorescein DiAcetate Succinimidyl Ester (CFDA-SE) labelled PBMCs stimulated with 1 and 10 μg/
ml Ci8 short peptide at indicated time points. A. Flow cytometric dot plots of one representative out of four individuals. Values inside the plots indicate the percentage of CFSE+/CD4+-
CFSE+/CD8+- CFSE+/CD16+/CD56+cells. B. Histograms show the percentage of CD4+ proliferating cells as the mean values± SD of four independent experiments (unstimulated
sample, white box; cells treated with 1 μg/ml Ci8 short, gray box; cells treated with 10 μg/ml Ci8 short, black box). Statistical signiﬁcance was determined using Student’s t-tests (two-
tailed): ns, not signiﬁcant; *P< 0.05.
Fig. 5. Ci8 short induces IFN-γ secretion in CD4+T lymphocytes. PBMCs from n = 4 donors were tested for IFN-γ production using a cell-surface aﬃnity matrix technology for the
analysis and enrichment of cytokine-secreting antigen-speciﬁc cells. A MFI IFN-γ+ unstimulated PBMCs (blue histogram) and Ci8 stimulated PBMCs (light blue histograms) from one
representative subject. B Histograms of mean value data ± SD for CD4+IFN-γ+ cells (white box unstimulated sample values, black box antigen induced). The trend line is in red. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
A. Bonura et al. Immunobiology 223 (2018) 210–219
216
MFI value increased from day 6 (P-value = 0.005) to day 8 (P-
value = 0.027) (Fig. 6F). All these results indicate that Ci8 short is
capable of inducing a CD4+CD25high T cell population characterized
by the expression of phenotypic and functional markers, such as
CD39/CD73 and LAP.
4. Discussion
Marine invertebrates produce a large number of unique and struc-
turally diversiﬁed natural products which represent an important
source of molecules exhibiting a wide range of bioactivities such as
anticancer, antiviral, antifungal, and antibacterial properties (Otero-
González et al., 2010; Cheung et al., 2015; Suarez-Jimenez et al., 2012).
An LPS challenge in Ciona intestinalis induces a CR-APA event encoding
for a Ci8 short transcript that is strongly up-regulated in immune cells
and present the 3′ UTR mRNA peculiar cis-regulatory elements essential
for innate immune responses. All this leading to the hypothesis that Ci8
short could have immunological activity. In these studies an in silico
analysis was performed to evaluate whether the peptide can be re-
cognized by the human immune system demonstrating that there are
diﬀerent HLA binding regions that are spread throughout the protein
sequence, and, therefore, we chose to ﬁrst characterize the entire pro-
tein regarding its possible role using human PBMCs as an in vitro system
(Davis, 2008; Germain and Schwartzberg, 2011). Also it would be in-
teresting to deﬁne exactly the binding sites for diﬀerent alleles and
study the more speciﬁc epitope mapping. Our data highlight that there
are putative MHC binding sequences, and this is necessary for re-
cognition by T cells but not suﬃcient to deﬁne and demonstrate im-
munogenicity of a Ci8 short peptide. The selective recognition of any
antigenic peptides binding with MCH (pMHC) by speciﬁc TCR requires
very complex and not fully known mechanisms based on spatio/tem-
poral integration of a panoply of triggers (Valitutti et al., 2010). Since
1995, the kinetic proof-reading model was described, postulating that
TCR/pMHC binding triggers a signaling cascade with several sequential
intermediates, but this is only true for stronger ligands. The perfect
assembly of the whole signaling cascade results in TCR activation and
Fig. 6. Ci8 short peptide induces the expression of CD39, CD73 and LAP on CD4+CD25high lymphocytes.
A. Dot plot showing the gating strategy of the multiparametric ﬂow cytometry analysis utilized for the selection of the CD4+CD25high cell population. B. Histograms showing the
percentage of CD4+CD25high cells of PBMCs unstimulated (white box) and incubated with 10 μg/ml Ci8 short peptide (black box) at six, seven and eight days after antigen stimulation.
Values indicate mean values ± SD of four independent experiments. Statistical signiﬁcance was determined using Student’s t-tests (two-tailed): ns, not signiﬁcant; *P < 0.05. C.
Representative experiment dot plots showing the multiparametric ﬂow cytometry analysis of unstimulated PBMCs and PBMCs incubated with 10 μg/ml Ci8 short peptide from day six to
eight. Numbers inside the graphs indicate the percentage of the CD39+CD73+ double positive cell population. D. Histograms show the multiparametric ﬂow cytometry analysis of
unstimulated PBMCs and PBMCs incubated with 10 μg/ml Ci8 short peptide from day six to eight. Numbers inside the graphs indicate the percentage of the CD39+CD73+LAP+ cell
population and the MFI value of LAP on the CD39+CD73+LAP+ cell population. Dot plots and histograms shown are representative of four individuals. E.Histogram showing the
percentage of CD4+CD25highCD39+CD73+LAP+ cells in unstimulated PBMCs (white box) and PBMCs incubated with 10 μg/ml Ci8 short peptide (black box) from day six to eight. The
values represent the mean±SD of four independent experiments. Statistical signiﬁcance was determined using Student’s t-tests (two-tailed): ns, not signiﬁcant; *P < 0.05.
F. Histogram showing the MFI value of LAP on CD4+CD25highCD39+CD73+LAP+ cells. The values represent the mean±SD of four independent experiments. Statistical signiﬁcance of
the diﬀerence between experimental groups was determined using Student’s t-test: ns, not signiﬁcant; *P < 0.05 **P < 0.01.
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ﬁnally in productive signal transduction (McKeithan, 1995). Despite
numerous and intensive investigations, we still do not understand how
the TCR transduces signals across the plasma membrane, a process re-
ferred to as TCR triggering. Three basic mechanisms have been pro-
posed, involving aggregation, conformational change or segregation of
the TCR upon binding to the pMHC ligand (Anton van der Merwe,
2001). The ﬁrst question is whether the Ci8 short peptide can exceed
the threshold of TCR activation (Rachmilewitz and Lanzavecchia,
2002). The time frame of T cell activation encompasses molecular
events occurring within seconds and sustained for hours or days up to
the acquisition of functional properties. In this context, the kinetics of
diﬀerent experiments has been developed. One of the earliest bio-
chemical events detected following TCR engagment is certainly ZAP-70
activation, a critical checkpoint in this complex pathway (Chan et al.,
1992; Wang et al., 2010). In the resting state of T-cells, ZAP-70 is dis-
tributed throughout the cytoplasm; following T cell engagement, the
earliest event is the phosphorylation of the Immunoreceptor Tyrosine-
based Activation Motifs (ITAMs) that promote recruitment and sub-
sequent activation of ZAP-70. Recent studies indicate that this event
also helps to release ZAP-70 from its autoinhibited conformation
(Hermiston et al., 2002; Klammt et al., 2015) and this triggers down-
stream events of the T cell signaling cascade. We demonstrated a clear
increase in the ZAP-70 MFI value on CD3+CD4+and CD3+CD8+ T
lymphocytes related to PBMCs treated without antigen and a compar-
ison between the percentages of ZAP-70 positive cells indicates that
there is an increase in CD4+ lymphocytes. The T cell activation based
on pMHC/TCR-speciﬁc interaction results in the clonal expansion of T
cells. The study of the human TCR repertoire has become an important
tool in studies of the immunological mechanisms in various physiolo-
gical and pathological conditions(Gran et al., 1998), but the analysis of
variable gene segment families is very complex (Arden et al., 1995;
Davis and Bjorkman, 1988). For example, for the β locus, 65 Vβ seg-
ments have been described and functional TCRβV families are grouped
into 24 families based on greater than 75% nucleotide sequence iden-
tity (Rowen et al., 1996). The most functionally relevant analysis of
TCR usage is the detection of the membrane surface proteins by ﬂow
cytometry. Our data strongly suggest that there is statistically sig-
niﬁcant increase in the percentage of CD4+ T lymphocytes bearing TCR
Vβ2, TCR Vβ8 and TCR Vβ20 in PBMCs primarily after Ci8 short
challenge. For CD8+ repertoire, a statistically signiﬁcant increase is
only obtained by the TCR Vβ14 clone. Then, the binding of TCR to
speciﬁc pMHC triggers distinct signaling events leading to T cell pro-
liferation, cytokine production and immunoregulation (Guy et al.,
2013). TCR has a central role in the control of T cell proliferation but
the signaling pathway remains obscure and there are many diﬃculties
for fully understanding these complex pathways. We investigated the
Ci8 molecule capabilities that drive the proliferative response and the
results obtained demonstrate that induction of CD4+ T lymphocyte
mainly proliferates but interestingly no signiﬁcant data were obtained
for CD8+ and CD16+/CD56+ cells. The TCR-driven pathways that lead
to proliferation appear separable to the secretion of cytokines, another
event that by immune cells deﬁnes a signiﬁcant part of their functional
activity (Guy et al., 2013). Our hypothesis is that Ci8 short cytokines
production is mediated by Eﬀector Memory T cells (TEM) (Farber, 2014)
that can produce these immediately after antigen challenge with a rapid
recall mechanism (Scheﬀold et al., 2000; Han et al., 2012; Campbell
et al., 2010). These events are also mediated by TCR engagement and
high ZAP-70 tyrosine kinase expression levels. There are encouraging
results on the role of IFN-γ in Ci8-mediated mechanisms especially by
CD4+ memory T lymphocytes and this in agreement with Farber et al.
(Farber, 2014) who demonstrated that the TEM subset has the highest
proportion IFN-γ producing cells. Eﬀector T cell stimulation by speciﬁc
antigens leads to an array of functional events optimally tailored to
provide an appropriate immune response that includes T cell selection,
proliferation and cytokine production by antigen speciﬁc T cells.
However, another way to respond to the antigen challenge is to activate
peripheral tolerance mechanisms (Li Mo and Rudensky, 2016; Zhu and
Shevach, 2014; Vignali et al., 2008). The central role of diﬀerent Treg
subsets (Abbas et al., 2013) in the immune response is unquestioned,
but their immunophenotypic characterization, especially in the human
system, is very diﬃcult to deﬁne. The identiﬁcation of the IL-2 receptor
(CD25) as a marker for natural Treg cells dates to 1995 (Sakaguchi
et al., 1995) and the up-regulation of CD25 expression is a signature
feature of human Treg. We demonstrate a statistically signiﬁcant in-
crease in a speciﬁc and rare CD4+CD25high population after antigen
stimulation and for these reasons we studied the expression of mole-
cules crucial for the delineation of functionality in vitro inducing Treg
cells (Abbas et al., 2013). In the human immune system, it is diﬃcult to
determine the more speciﬁc markers for deﬁning in vitro Treg. We also
studied LAP (Andersson, 2008; Tran, 2009), CD39 (Borsellino et al.,
2007; Dwyer et al., 2010) and CD73 (Deaglio et al., 2007; Schuler et al.,
2014) as functional markers especially because they are not expressed
constitutively on resting and expanded Treg but are rapidly induced on
activated Treg. In this paper, we describe not only an increased number
of positive cells that co-express these functional markers but a clear MFI
positive shift after antigen challenge, especially for CD73 and LAP ex-
pression. The coexistence of two crucial regulatory pathway molecules
in CD4+CD25high Ci8 short-induced cells encourages us to implement
the studies to answer the questions about mechanisms of actions of this
iTreg subset. In conclusion, all the experimental evidence that has ac-
cumulated thus far supports the idea that Ci8 short is directly involved
in many important events of TCR-mediated immunity but the role of
Ci8 short has begun to be studied but its exact functions in the adaptive
immune system requires further exploration. Moreover, we could de-
monstrate that Ci8 short improves CD4+ immune responses allowing us
to hypothesize that can be used as a really useful tools to study the
immunological conditions in which the CD4+ T lymphocyte responses
are reduced.
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